Endovascular treatment for ruptured abdominal aortic aneurysm

Published on May 26, 2017in Cochrane Database of Systematic Reviews7.89
· DOI :10.1002/14651858.CD005261.PUB4
Stephen A. Badger4
Estimated H-index: 4
(Mater Misericordiae University Hospital),
Rachel Forster8
Estimated H-index: 8
(Edin.: University of Edinburgh)
+ 3 AuthorsDenis W. Harkin21
Estimated H-index: 21
(Royal Victoria Regional Health Centre)
Sources
Abstract
Background An abdominal aortic aneurysm (AAA) (pathological enlargement of the aorta) is a condition that can occur as a person ages. It is most commonly seen in men older than 65 years of age. Progressive aneurysm enlargement can lead to rupture and massive internal bleeding, which is fatal unless timely repair can be achieved. Despite improvements in perioperative care, mortality remains high (approximately 50%) after conventional open surgical repair. Endovascular aneurysm repair (EVAR), a minimally invasive technique, has been shown to reduce early morbidity and mortality as compared to conventional open surgery for planned AAA repair. More recently emergency endovascular aneurysm repair (eEVAR) has been used successfully to treat ruptured abdominal aortic aneurysm (RAAA), proving that it is feasible in select patients; however, it is unclear if eEVAR will lead to significant improvements in outcomes for these patients or if indeed it can replace conventional open repair as the preferred treatment for this lethal condition. This is an update of the review first published in 2006. Objectives To assess the advantages and disadvantages of emergency endovascular aneurysm repair (eEVAR) in comparison with conventional open surgical repair for the treatment of ruptured abdominal aortic aneurysm (RAAA). This will be determined by comparing the effects of eEVAR and conventional open surgical repair on short-term mortality, major complication rates, aneurysm exclusion (specifically endoleaks in the eEVAR treatment group), and late complications. Search methods For this update the Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register (last searched June 2016), CENTRAL (2016, Issue 5), and trials registries. We also checked reference lists of relevant publications. Selection criteria Randomised controlled trials in which participants with a clinically or radiologically diagnosed RAAA were randomly allocated to eEVAR or conventional open surgical repair. Data collection and analysis Two review authors independently assessed studies identified for potential inclusion for eligibility. Two review authors also independently completed data extraction and quality assessment. Disagreements were resolved through discussion. We performed meta-analysis using fixed-effect models with odds ratios (ORs) and 95% confidence intervals (CIs) for dichotomous data and mean differences with 95% CIs for continuous data. Main results We included four randomised controlled trials in this review. A total of 868 participants with a clinical or radiological diagnosis of RAAA were randomised to receive either eEVAR or open surgical repair. Overall risk of bias was low, but we considered one study that performed randomisation in blocks by week and performed no allocation concealment and no blinding to be at high risk of selection bias. Another study did not adequately report random sequence generation, putting it at risk of selection bias, and two studies were underpowered. There was no clear evidence to support a difference between the two interventions for 30-day (or in-hospital) mortality (OR 0.88, 95% CI 0.66 to 1.16; moderate-quality evidence). There were a total of 44 endoleak events in 128 participants from three studies (low-quality evidence). Thirty-day complication outcomes (myocardial infarction, stroke, composite cardiac complications, renal complications, severe bowel ischaemia, spinal cord ischaemia, reoperation, amputation, and respiratory failure) were reported in between one and three studies, therefore we were unable to draw a robust conclusion. We downgraded the quality of the evidence for myocardial infarction, renal complications, and respiratory failure due to imprecision, inconsistency, and risk of bias. Odds ratios for complications outcomes were OR 2.38 (95% CI 0.34 to 16.53; 139 participants; 2 studies; low-quality evidence) for myocardial infarction; OR 1.07 (95% CI 0.21 to 5.42; 255 participants; 3 studies; low-quality evidence) for renal complications; and OR 3.62 (95% CI 0.14 to 95.78; 32 participants; 1 study; low-quality evidence) for respiratory failure. There was low-quality evidence of a reduction in bowel ischaemia in the eEVAR treatment group, but very few events were reported (OR 0.37, 95% CI 0.14 to 0.94), and we downgraded the evidence due to imprecision and risk of bias. Six-month and one-year outcomes were evaluated in three studies, but only results from a single study could be used for each outcome, which showed no clear evidence of a difference between the interventions. We rated six-month mortality evidence as of moderate quality due to imprecision (OR 0.89, 95% CI 0.40 to 1.98; 116 participants). Authors' conclusions The conclusions of this review are currently limited by the paucity of data. We found from the data available moderate-quality evidence suggesting there is no difference in 30-day mortality between eEVAR and open repair. Not enough information was provided for complications for us to make a well-informed conclusion, although it is possible that eEVAR is associated with a reduction in bowel ischaemia. Long-term data were lacking for both survival and late complications. More high-quality randomised controlled trials comparing eEVAR and open repair for the treatment of RAAA are needed to better understand if one method is superior to the other, or if there is no difference between the methods on relevant outcomes.
Download
📖 Papers frequently viewed together
256 Citations
226 Citations
476 Citations
References112
Newest
#1J. Jacomelli (PHE: Public Health England)H-Index: 6
#2L. Summers (PHE: Public Health England)H-Index: 4
Last. Jonothan J. Earnshaw (Gloucestershire Hospitals NHS Foundation Trust)H-Index: 38
view all 5 authors...
Background The Abdominal Aortic Aneurysm (AAA) Screening Programme was introduced by the National Health Service (NHS) in England to reduce the rate of death from ruptured AAA in men. The programme commenced in 2009 and was implemented completely across the country in April 2013. The aim was to review the first 5 years of the programme, looking specifically at compliance and early outcome. Methods Men aged 65 years were invited for a single abdominal ultrasound scan. Data were entered into a bes...
83 CitationsSource
Objectives/Background ECAR (Endovasculaire ou Chirurgie dans les Anevrysmes aorto-iliaques Rompus) is a prospective multicentre randomized controlled trial including consecutive patients with ruptured aorto-iliac aneurysms (rAIA) eligible for treatment by either endovascular (EVAR) or open surgical repair (OSR). Inclusion criteria were hemodynamic stability and computed tomography scan demonstrating aorto-iliac rupture. Methods Randomization was done by week, synchronously in all centers. The pr...
106 CitationsSource
#1Michael J. Sweeting (University of Cambridge)H-Index: 50
#2P. Ulug (Charing Cross Hospital)H-Index: 2
Last. R. BalmH-Index: 3
view all 5 authors...
Objective To assess current knowledge for the management of ruptured abdominal aortic aneurysm (AAA), based on the 1-year outcomes of 3 recent randomised trials. Methods An individual patient data meta-analysis of three recent randomised trials of endovascular versus open repair, including 817 patients, was conducted according to a pre-specified analysis plan, report all-cause mortality and re-interventions at 1 year after the index event. Results Mortality across the 3 trials at 1-year was 38.6...
49 CitationsSource
#1Michael J. Sweeting (University of Cambridge)H-Index: 50
#2R. BalmH-Index: 3
Last. Janet T. Powell (Charing Cross Hospital)H-Index: 85
view all 5 authors...
Background The benefits of endovascular repair of ruptured abdominal aortic aneurysm remain controversial, without any strong evidence about advantages in specific subgroups. Methods An individual-patient data meta-analysis of three recent randomized trials of endovascular versus open repair of abdominal aortic aneurysm was conducted according to a prespecified analysis plan, reporting on results to 90 days after the index event. Results The trials included a total of 836 patients. The mortality...
60 CitationsSource
Aims To report the longer term outcomes following either a strategy of endovascular repair first or open repair of ruptured abdominal aortic aneurysm, which are necessary for both patient and clinical decision-making. Methods and results This pragmatic multicentre (29 UK and 1 Canada) trial randomized 613 patients with a clinical diagnosis of ruptured aneurysm; 316 to an endovascular first strategy (if aortic morphology is suitable, open repair if not) and 297 to open repair. The principal 1-yea...
107 CitationsSource
Aims To investigate whether aneurysm shape and extent, which indicate whether a patient with ruptured abdominal aortic aneurysm (rAAA) is eligible for endovascular repair (EVAR), influence the outcome of both EVAR and open surgical repair. Methods and results The influence of six morphological parameters (maximum aortic diameter, aneurysm neck diameter, length and conicality, proximal neck angle, and maximum common iliac diameter) on mortality and reinterventions within 30 days was investigated ...
57 CitationsSource
Background There is clinical equipoise between open (OR) and endovascular aneurysm repair (EVAR) for the best treatment of ruptured abdominal aortic aneurysm (RAAA). Objective The aim of the study was to perform a systematic review and meta-analysis to estimate the short-term (combined 30-day or in-hospital) survival after EVAR and OR for patients with RAAA. Data sources included Medline, Embase, and the World Health Organization International Clinical Trials Registry until 13 January 2014. All ...
82 CitationsSource
#1Graeme K. Ambler (Cambridge University Hospitals NHS Foundation Trust)H-Index: 13
#2Christopher P. Twine (Cambridge University Hospitals NHS Foundation Trust)H-Index: 20
Last. Jonathan R. Boyle (Cambridge University Hospitals NHS Foundation Trust)H-Index: 31
view all 8 authors...
Objectives The first large-scale randomised trial (Immediate Management of the Patient with Rupture: Open Versus Endovascular repair [IMPROVE]) for endovascular repair of ruptured abdominal aortic aneurysm (rEVAR) has recently finished recruiting patients. The aim of this study was to examine the impact on survival after rEVAR when the IMPROVE protocol was initiated in a high volume abdominal aortic aneurysm (AAA) centre previously performing rEVAR. Methods One hundred and sixty-nine patients re...
10 CitationsSource
#1Alan Karthikesalingam (St George's, University of London)H-Index: 54
#2Peter J. Holt (St George's, University of London)H-Index: 55
Last. Matt M. Thompson (St George's, University of London)H-Index: 81
view all 7 authors...
Summary Background The outcome of patients with ruptured abdominal aortic aneurysm (rAAA) varies by country. Study of practice differences might allow the formulation of pathways to improve care. Methods We compared data from the Hospital Episode Statistics for England and the Nationwide Inpatient Sample for the USA for patients admitted to hospital with rAAA from 2005 to 2010. Primary outcomes were in-hospital mortality, mortality after intervention, and decision to follow non-corrective treatm...
180 CitationsSource
#1M. R. KapmaH-Index: 7
#2Lea M. DijksmanH-Index: 18
Last. Anco C. VahlH-Index: 22
view all 9 authors...
Background: Minimally invasive endovascular aneurysm repair (EVAR) could be a surgical technique that improves outcome of patients with ruptured abdominal aortic aneurysm (rAAA). The aim of this study was to analyse the cost-effectiveness and cost-utility of EVAR compared with standard open repair (OR) in the treatment of rAAA, with costs per 30-day and 6-month survivor as outcome parameters. Methods: Resource use was determined from the Amsterdam Acute Aneurysm (AJAX) trial, a multicentre rando...
23 CitationsSource
Cited By125
Newest
Source
#1Gabriella Teti (UNIBO: University of Bologna)H-Index: 17
#2Francesca Chiarini (National Research Council)H-Index: 33
Last. Mirella Falconi (UNIBO: University of Bologna)H-Index: 28
view all 6 authors...
Cellular senescence is a hallmark of ageing and it plays a key role in the development of age-related diseases. Abdominal aortic aneurysm (AAA) is an age related degenerative vascular disorder, characterized by a progressive dilatation of the vascular wall and high risk of rupture over time. Nowadays, no pharmacological therapies are available and the understanding of the molecular mechanisms that lead to AAA onset and development are poorly defined. In this study we investigated the cellular fe...
Source
#1Jianqing Deng (Chinese PLA General Hospital)
#2Jie Liu (Chinese PLA General Hospital)H-Index: 5
Last. Wei Guo (Chinese PLA General Hospital)H-Index: 15
view all 7 authors...
Abstract Objective To conduct a meta-analytic review of studies investigating the effect of the anesthesia modality on perioperative mortality in endovascular repair of ruptured abdominal aortic aneurysms (REVAR). Methods The present meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Multiple electronic databases were comprehensively searched from database inception to January 2020. Eligible studies included cohort st...
Source
#1Matthew S. Thiese (UofU: University of Utah)H-Index: 24
#1Matthew S. Thiese (CHA: Cambridge Health Alliance)
Last. Kurt T. HegmannH-Index: 27
view all 7 authors...
Commercial Motor Vehicle drivers must be medically certified to obtain/maintain a commercial driver license. 88,246 exams from 2005 to 2012 were analyzed for relationships between health and certification length. Relationships were quantified using adjusted odds ratios (ORs). Most conditions and/or examination findings had statically significantly limited medical certification. Obesity > 35 kg/m2, hypertension and diabetes mellitus requiring medication were most common. Significant and meaningfu...
Source
#1Yu-Hsien Lee (CGU: Chang Gung University)
#2Ta-Wei Su (CGU: Chang Gung University)H-Index: 5
Last. Po-Jen Ko (CGU: Chang Gung University)H-Index: 15
view all 10 authors...
Abstract Purpose: To evaluate the short-term outcome of totally percutaneous endovascular aortic repair (pEVAR) of ruptured abdominal aortic aneurysms (AAAs) compared with femoral cut-down endovascular aortic repair (cEVAR). Materials and methods: The medical records of patients with ruptured AAAs that underwent EVAR between March 2010 and April 2017 were retrospectively reviewed. Demographic information, preoperative vital signs, preoperative laboratory data, method of anesthesia, procedure dur...
Source
#1Shiyun XieH-Index: 1
#2Li MaH-Index: 1
Last. Chanchan HanH-Index: 1
view all 6 authors...
Rupture of abdominal aortic aneurysm (AAA) is a devastating event that can be prevented by inhibiting the growth of small aneurysms. Therapeutic strategies targeting certain events that promote the development of AAA must be developed, in order to alter the course of AAA. Chronic inflammation of the aortic mural is a major characteristic of AAA and is related to AAA formation, development and rupture. Daphnetin (DAP) is a coumarin derivative with anti-inflammatory properties that is extracted fr...
1 CitationsSource
#1Wolf Eilenberg (Medical University of Vienna)H-Index: 7
#2Michael Schwarz (Medical University of Vienna)H-Index: 2
Last. Christoph Domenig (Medical University of Vienna)H-Index: 8
view all 10 authors...
Abstract Background To compare open repair (OR) with EVAR for the management of ruptured infrarenal abdominal aortic aneurysms (RAAA) in a cohort study over a time period of 15 years with inverse probability of treatment weights. Material and Methods From 2000/01 through 2015/12 136 patients were treated for RAAA, 98 (72.1%) underwent OR, 38 (27.9%) were treated with EVAR. Thirty-day and long-term mortality (survival) were analyzed in this IRB-approved retrospective cohort study. Treatment modal...
Source
#1Anair Beverly (NHSBT: NHS Blood and Transplant)H-Index: 1
#2Giok Ong (NHSBT: NHS Blood and Transplant)H-Index: 1
Last. Lise J Estcourt (NHSBT: NHS Blood and Transplant)H-Index: 26
view all 5 authors...
Source
#1Janet T. Powell (Imperial College London)H-Index: 85
#2Anders Wanhainen (Umeå University)H-Index: 42
Objective The aim was to understand why two recently published guidelines for the diagnosis and management of patients with abdominal aortic aneurysm, the National Institute for Health and Care Excellence (NICE) 2020 guidelines and the European Society for Vascular Surgery (ESVS) 2019 guidelines, have discordant recommendations in several important areas. Methods A review of the approach, methodology, and evidence used by the two guideline committees was carried out to understand potential reaso...
4 CitationsSource
#1Eleonora G. Karthaus (LUMC: Leiden University Medical Center)H-Index: 7
#2Niki Lijftogt (LUMC: Leiden University Medical Center)H-Index: 4
Last. M.L. van ZeelandH-Index: 2
view all 312 authors...
Abstract Objective While several observational studies suggested a lower postoperative mortality after minimal invasive endovascular aneurysm repair (EVAR) in RAAA-patients compared to conventional open surgical repair (OSR), landmark RCTs have not been able to prove the superiority of EVAR over OSR. RCTs contain a selected, homogeneous population, influencing external validity. Observational studies are biased and adjustment of confounders can be incomplete. Instrumental variable (IV)-analysis ...
Source